Corticosteroids and ARDS: A review of treatment and prevention evidence

Lung India

Volumn 28, Issue 2, 2011, Pages 114-119

  Khilnani, G C ^a   Hadda, Vijay ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acute respiratory distress syndrome; adult respiratory distress syndrome; corticosteroids; methylprednisolone

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; INSULIN; METHYLPREDNISOLONE;

ADULT RESPIRATORY DISTRESS SYNDROME; ADVERSE OUTCOME; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FLUID RETENTION; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INFECTION; INFECTION RATE; INTENSIVE CARE UNIT; LENGTH OF STAY; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG FUNCTION; LUNG INJURY; MENTAL DISEASE; META ANALYSIS; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; NONHUMAN; PANCREATITIS; REVIEW; SCORING SYSTEM; SIDE EFFECT; SUPERINFECTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; VENTILATOR;

EID: 79960254625     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.80324     Document Type: Review

References (45)

1. Bernard GR. Acute respiratory distress syndrome: A historical perspective. Am J Respir Crit Care Med 2005;172:798-806.
2. Leaver SK, Evans TW. Acute respiratory distress syndrome. BMJ 2007;335:389-94. (Pubitemid 47359318)
3. Rubenfeld GD, Herridge MS. Epidemiology and outcomes of acute lung injury. Chest 2007;131:554-62. (Pubitemid 46280419)
4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49. (Pubitemid 30408719)
5. Tomashefski JF, Jr. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990;11:593-619.
6. Steinberg KP, Milberg JA, Martin TR, Maunder RJ, Cockrill BA, Hudson LD. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;150:113-22. (Pubitemid 24209946)
7. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1896-903. (Pubitemid 33152327)
8. Raghu G, Striker LJ, Hudson LD, Striker GE. Extracellular matrix in normal and fibrotic human lungs. Am Rev Respir Dis 1985;131:281-9. (Pubitemid 15167076)
9. Lamy M, Fallat RJ, Koeniger E, Dietrich HP, Ratliff JL, Eberhart RC, et al. Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis 1976;114:267-84.
10. Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment. Arch Surg 1985;120:530-5. (Pubitemid 15053407)
11. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8.
12. Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996;334:1417-21. (Pubitemid 26157436)
13. Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis K Jr, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: A randomized controlled trial. JAMA 2004;291:1603-9. (Pubitemid 38552433)
14. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. The ARDS Network. JAMA 2000;283:1995-2002.
15. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study. Crit Care Med 1992;20:918-23.
16. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 1997;112:164-72. (Pubitemid 27343614)
17. Suter PM. Lung Inflammation in ARDS-friend or foe? N Engl J Med 2006;354:1739-42.
18. Hirabayashi T, Murayama T, Shimizu T. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharm Bull 2004;27:1168-73. (Pubitemid 41701705)
19. Solito E, de Coupade C, Parente L, Flower RJ, Russo-Marie F. IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine 1998;10:514-21. (Pubitemid 28342677)
20. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005;353:1711-23.
21. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987;317:1565-70. (Pubitemid 18014383)
22. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial. JAMA 1998;280:159-65. (Pubitemid 28498389)
23. Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006;34:22-30. (Pubitemid 43032376)
24. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-84.
25. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest 2007;131:954-63. (Pubitemid 46608692)
26. Weigelt JA, Norcross JF, Borman KR, Snyder WH 3rd. Early steroid therapy for respiratory failure. Arch Surg 1985;120:536-40. (Pubitemid 15053408)
27. Schein RM, Bergman R, Marcial EH, Schultz D, Duncan RC, Arnold PI, et al. Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome. Chest 1987;91:850-4.
28. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987;92:1032-6. (Pubitemid 18026542)
29. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138:62-8.
30. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003;167:512-20.
31. Rosenberg JC, Lysz K. An in vitro study of how much methylprednisolone is needed to produce immunosuppression. Proc Clin Dial Transplant Forum 1977;7:23-8.
32. Yates CR, Vysokanov A, Mukherjee A, Ludden TM, Tolley E, Meduri GU, et al. Time-variant increase in methylprednisolone clearance in patients with acute respiratory distress syndrome: A population pharmacokinetic study. J Clin Pharmacol 2001;41:415-24. (Pubitemid 32274985)
33. Hesterberg TW, Last JA. Ozone-induced acute pulmonary fibrosis in rats. Prevention of increased rates of collagen synthesis by methylprednisolone. Am Rev Respir Dis 1981;123:47-52. (Pubitemid 11188640)
34. Hakkinen PJ, Schmoyer RL, Witschi HP. Potentiation of butylatedhydroxytoluene- induced acute lung damage by oxygen. Effects of prednisolone and indomethacin. Am Rev Respir Dis 1983;128:648-51.
35. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73. (Pubitemid 38344143)
36. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008;34:17-60.
37. Hooper RG, Kearl RA. Established ARDS treated with a sustained course of adrenocortical steroids. Chest 1990;97:138-43. (Pubitemid 20023507)
38. Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper KV Jr. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 1991;100:943-52.
39. Meduri GU, Chinn AJ, Leeper KV, Wunderink RG, Tolley E, Winer- Muram HT, et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest 1994;105:1516-27. (Pubitemid 24152615)
40. Estenssoro E, Gonzalez F, Laffaire E, Canales H, Saenz G, Reina R, et al. Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. Chest 2005;127:598-603. (Pubitemid 40229323)
41. Vieillard-Baron A, Girou E, Valente E, Brun-Buisson C, Jardin F, Lemaire F, et al. Predictors of mortality in acute respiratory distress syndrome. Focus On the role of right heart catheterization. Am J Respir Crit Care Med 2000;161:1597-601. (Pubitemid 30329034)
42. Nash G. Pathology of ARDS. West J Med 1979;130:220-2.
43. Meduri GU, Marik PE, Chrousos GP, Pastores SM, Arlt W, Beishuizen A, et al. Steroid treatment in ARDS: A critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008;34:61-9.
44. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroidsin acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. Crit Care Med 2009;37:1594-603.
45. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: Meta-analysis. BMJ 2008;336:1006-9. (Pubitemid 351656093)